PEPG Stock Summary and Trading Ideas (Pepgen | NASDAQ:PEPG)

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.

Pepgen trades on the NASDAQ stock market under the symbol PEPG.

As of January 17, 2025, PEPG stock price declined to $2.30 with 127,787 million shares trading.

PEPG has a market cap of $74.96 million. This is considered a Micro Cap stock.

The top ETF exchange traded funds that PEPG belongs to (by Net Assets): VTI, VXF, IWM, IBB, IWO.

PEPG has underperformed the market in the last year with a price return of -66.4% while the SPY ETF gained +28.0%. PEPG has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -74.1% and -39.9%, respectively, while the SPY returned +3.0% and +1.0%, respectively.

PEPG support price is $2.24 and resistance is $2.60 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PEPG shares will trade within this expected range on the day.